Edition:
United States

People: Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

50.60USD
27 Mar 2017
Change (% chg)

$0.15 (+0.30%)
Prev Close
$50.45
Open
$50.05
Day's High
$50.75
Day's Low
$50.00
Volume
44,043
Avg. Vol
75,996
52-wk High
$62.50
52-wk Low
$38.35

Dixon, Rosina 

Dr. Rosina B. Dixon, M.D., is Independent Director of Cambrex Corporation. She is a Chairperson of the Compensation Committee and Member of the Regulatory Affairs Committee of the Board. Dr. Dixon has been Medical Director, Advance Biofactures Corp., a pharmaceuticals company in Lynbrook, NY, since January 2012. Prior to that she was Senior Director, Global Pharmacovigilance and Epidemiology at Sanofi-Aventis, a global biopharmaceuticals company located in Bridgewater, NJ from 2006 to 2011. From May 1986 to September 2006 she was a consultant to the pharmaceutical industry. Dr. Dixon previously served as Vice President and Secretary of Medical Market Specialties Incorporated, as well as a member of its Board of Directors. She was also previously Medical Director, Schering Laboratories, Schering-Plough Corporation. Prior to that, Dr. Dixon was Executive Director Biodevelopment, Pharmaceuticals Division, CIBA-GEIGY Corporation. Dr. Dixon had been a member of the Board of Directors of Church & Dwight Co., Inc. since 1979 until her retirement in May 2014.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 49,995
Long-Term Incentive Plans, USD --
All Other, USD 103,003
Fiscal Year Total, USD 152,998

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

324,994

Steven Klosk

3,761,460

Tom Vadaketh

--

Shawn Cavanagh

2,784,210

Gregory Sargen

2,519,810

Samantha Hanley

1,062,810
As Of  30 Dec 2015